Tiansheng Pharmaceutical Group Co., Ltd. (002872.SZ)
CNY 4.76
(-0.83%)
CNY 4.76
(-0.83%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -24.56 Million | 89.18 Million | 18.97 Million | 189.75 Million | 144.2 Million | 153.98 Million |
| Net Income | -93.71 Million | -91.55 Million | -72.33 Million | -493.58 Million | -218.93 Million | 117.5 Million |
| Depreciation & Amortization | 107.25 Million | 107.72 Million | 89.99 Million | 117.05 Million | 106.06 Million | 108.5 Million |
| Deferred income taxes | -1.4 Million | 4.23 Million | 30.37 Million | -44.45 Million | -12.91 Million | -596.76 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -79.99 Million | 47.34 Million | -33.33 Million | 116.28 Million | 128.16 Million | -150.75 Million |
| Other non-cash items | 17.23 Million | 25.66 Million | 34.65 Million | 449.99 Million | 128.92 Million | 78.73 Million |
| Investing Cash Flow | -82.08 Million | -65.56 Million | 169.58 Million | -76.14 Million | -128.56 Million | -160.89 Million |
| Investments in PPE | -76.73 Million | -73.42 Million | -114.38 Million | -92.7 Million | -93.23 Million | -234.26 Million |
| Acquisitions | 15.05 Million | 22.45 Million | 31.07 Million | 7.1 Million | 3.53 Million | -39.23 Million |
| Investment purchases | -330 Million | -188 Million | -152.7 Million | -202.07 Million | -142.5 Million | -100 Million |
| Sales/Maturities of investments | 331.9 Million | 271.82 Million | 398.64 Million | 201.31 Million | 102.49 Million | 201.21 Million |
| Other Investing Activities | -22.3 Million | -98.42 Million | 6.93 Million | 10.2 Million | 1.15 Million | 11.38 Million |
| Financing Cash Flow | -11.2 Million | -44.47 Million | -138.96 Million | -134.57 Million | -33.79 Million | -273.61 Million |
| Debt repayment | -4.73 Million | -163.59 Million | -354.39 Million | -726.83 Million | -570.56 Million | -560.32 Million |
| Dividends payments | -15.53 Million | -15.93 Million | -22.89 Million | -37.18 Million | -34.74 Million | -93.01 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -396.45 Thousand | 135.05 Million | 238.31 Million | 629.44 Million | 571.52 Million | 379.72 Million |
| Accounts receivables | 103.03 Million | 54.68 Million | -419.08 Million | 277.35 Million | 35.02 Million | 81.35 Million |
| Accounts payables | -231.09 Million | -4.71 Million | 187.8 Million | -112.93 Million | -23.47 Million | -183.77 Million |
| Inventory | 49.46 Million | -6.86 Million | 167.56 Million | -3.68 Million | 128.77 Million | 47.99 Million |
| Other working capital | 2.16 Million | 4.23 Million | 30.37 Million | -44.45 Million | -12.15 Million | -198.74 Million |
| Cash at beginning of period | 278.25 Million | 299.1 Million | 249.52 Million | 270.48 Million | 287.32 Million | 567.97 Million |
| Cash at end of period | 160.4 Million | 278.25 Million | 299.1 Million | 249.52 Million | 269.2 Million | 287.32 Million |
| Capital Expenditure | -76.73 Million | -73.42 Million | -114.38 Million | -92.7 Million | -93.23 Million | -234.26 Million |
| Effect of forex changes on cash | - | 0.94 | 0.31 | 0.53 | 23.58 Thousand | -130.84 Thousand |
| Net cash flow / Change in cash | -117.84 Million | -20.85 Million | 49.58 Million | -20.96 Million | -18.12 Million | -280.65 Million |
| Free Cash Flow | -101.29 Million | 15.76 Million | -95.41 Million | 97.05 Million | 50.96 Million | -80.28 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 6.75 Million | -22.64 Million | -20.46 Million | -11.24 Million | -93.71 Million | -31.04 Million |
| Depreciation & Amortization | - | 27.9 Million | 27.9 Million | 28.04 Million | 107.25 Million | 28.04 Million |
| Deferred income taxes | - | - | - | - | -1.4 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 16.24 Million | - | - | -79.99 Million | - |
| Other non-cash items | -7.14 Million | 51.92 Million | 24.87 Million | 97.72 Million | 17.23 Million | -8.14 Million |
| Investing Cash Flow | 87.87 Million | -73.77 Million | -13.3 Million | -56.37 Million | -82.08 Million | -13.21 Million |
| Investments in PPE | -14.14 Million | -25.21 Million | -13.78 Million | -29.24 Million | -76.73 Million | -15.07 Million |
| Acquisitions | 20.42 Million | 23.42 Thousand | 13.66 Thousand | -60 Thousand | 15.05 Million | 94.25 Thousand |
| Investment purchases | - | - | - | -280 Million | -330 Million | -94.25 Thousand |
| Sales/Maturities of investments | - | 173.1 Thousand | 1 Million | 281.1 Million | 331.9 Million | 157.91 Thousand |
| Other Investing Activities | 81.59 Million | -48.57 Million | 461.82 Thousand | -27.19 Million | -22.3 Million | 1.71 Million |
| Financing Cash Flow | -7.85 Million | -22.79 Million | 106.88 Million | -86.5 Million | -11.2 Million | -5.38 Million |
| Debt repayment | -470 Thousand | -18.73 Million | -110.9 Million | -83.96 Million | -4.73 Million | -15.1 Million |
| Dividends payments | - | -4.7 Million | -2.84 Million | -3.96 Million | -15.53 Million | -4.39 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -8.32 Million | -3.54 Million | -4.01 Million | 1.42 Million | -396.45 Thousand | 14.11 Million |
| Accounts receivables | - | 2.48 Million | - | - | 103.03 Million | - |
| Accounts payables | - | - | - | - | -231.09 Million | - |
| Inventory | - | 13.75 Million | - | - | 49.46 Million | - |
| Other working capital | - | - | - | - | 2.16 Million | - |
| Cash at beginning of period | 248.81 Million | 295.54 Million | 245.97 Million | 245.97 Million | 278.25 Million | 303.9 Million |
| Cash at end of period | 243.03 Million | 248.81 Million | 295.54 Million | 160.4 Million | 160.4 Million | 245.97 Million |
| Capital Expenditure | -14.14 Million | -25.21 Million | -13.78 Million | -29.24 Million | -76.73 Million | -15.07 Million |
| Effect of forex changes on cash | - | - | - | - | - | -157.91 Thousand |
| Net cash flow / Change in cash | -5.78 Million | -46.73 Million | 49.57 Million | -85.56 Million | -117.84 Million | -57.93 Million |
| Free Cash Flow | -14.53 Million | -23.83 Million | -9.37 Million | 29.18 Million | -101.29 Million | -54.26 Million |
R35
HNL
AOMD
600968
ELECTHERM
MARK